This study, named "Check it," is a bundled program for African American (AA) men ages 15-24 that includes community testing for chlamydia and gonorrhea, expedited treatment for subjects who test positive and their female sexual contacts, and rescreening for these two sexually transmitted infections.



Eligible Ages
Between 15 Years and 24 Years
Eligible Genders
Accepts Healthy Volunteers

Inclusion Criteria

  • Identifies as African American or Black
  • Identifies as male
  • 15-24 years of age
  • Lives or spends most of his time in Orleans Parish
  • Had vaginal sex with at least one woman
  • Has not taken azithromycin in the past 7 days

Exclusion Criteria

  • Unwilling or unable to provide informed consent
  • Unable to speak or understand English
  • Previously enrolled in the study by self-report

Study Design

Study Type
Intervention Model
Single Group Assignment
Intervention Model Description
Community based screening of young men for chlamydia and gonorrhea, expedited treatment for positive subjects and their sexual partners
Primary Purpose
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Ct/GC screening
Community screening of men for Ct and GC is not normally done. We are testing to see if this intervention will impact the rates of Ct and GC among women
  • Other: Ct/GC screening
    Men aged 15-24 years old will be tested for chlamydia and gonorrhea at community based venues; positive men and their sexual partners will be offered expedited treatment at participating pharmacies; positive men will be asked to be rescreened for Ct/GC at 3 months post treatment.

Recruiting Locations

Tulane University School of Public Health and Tropical Medicine
New Orleans, Louisiana 70112
Patricia Kissinger, Ph.D.

More Details

Tulane University

Study Contact

Patricia J Kissinger, PhD

Detailed Description

Participants (N=4854) will be recruited through community partners, at events and using social marketing campaigns including advertisements, referrals from other participants, social media, and a web based educational website (Web-Ed). After establishing eligibility, written informed consent will be obtained. Subjects will complete a survey and provide a urine specimen for chlamydia (Ct) and gonorrhea (GC) testing and will provide their preferred contact information in order to be contacted about their test results. The testing laboratory will report positive results per LA hygiene code LAC 51:II.105: http://ldh.la.gov/assets/oph/Center-PHCH/Center-CH/infectious-epi/Surveillance/sanitarycode.p df. Tulane study staff will contact participants to inform them of their results. If the participant tests positive for Ct and/or GC, he will be offered expedited treatment for him and his recent sex partners. He may choose to pick up medication at a local pharmacy or medication can be mailed to him. Staff will also ask the participant to contact his partner(s) and provide them with the Check It staff's contact information so that staff can let the partner know that they have been exposed to an infection and offer her expedited treatment options if the participant did not already provide her with that information. No information provided by the participant will be shared with his partners. The study will cover the cost of the medications for subjects who test positive for either or both organisms and their sexual partners. Three months after treatment, male subjects who were positive will be asked to be re-screened and if positive, staff will conduct similar expedited treatment and partner services. Any subject who provides consent for annual testing reminders will be reminded using their preferred method of contact.


Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.